Michael Barbella, Managing Editor02.27.24
Caldera Medical has appointed John Pitstick as chief financial officer (CFO) and executive vice president of Corporate Development.
With a strategic focus on advancing Caldera Medical's position in the women’s health sector, Caldera Medical completed its acquisition of Atlantic Therapeutics last fall and maintains an innovation and operations team in Ireland as its European headquarters. Pitstick's appointment aligns with the company's accelerated growth and ambitious plans for future acquisitions.
Pitstick began his career with Ernst & Young, managing a global client base and contributing to several IPOs. His career as a CFO is marked by significant achievements in growing both private and publicly traded technology and healthcare companies. Pitstick’s financial acumen and strategic insight is underscored by his role as a board member of a publicly traded financial services company, where he also serves as chairman of that board's audit committee.
As CFO, Pistick's expertise in leading mergers and acquisitions (M&A) will be pivotal. His experience in overseeing transactions exceeding $3 billion, coupled with his success in raising more than $1 billion in financing, enables him to guide Caldera Medical through its ambitious expansion plans, including strategic acquisitions that will enhance the company’s portfolio and market presence.
Caldera Medical is a medical device company solely focused on women’s health. It develops, manufactures, and markets surgical products for treating stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids. The firm aims to treat 1 million women in underserved populations globally by next year.
With a strategic focus on advancing Caldera Medical's position in the women’s health sector, Caldera Medical completed its acquisition of Atlantic Therapeutics last fall and maintains an innovation and operations team in Ireland as its European headquarters. Pitstick's appointment aligns with the company's accelerated growth and ambitious plans for future acquisitions.
Pitstick began his career with Ernst & Young, managing a global client base and contributing to several IPOs. His career as a CFO is marked by significant achievements in growing both private and publicly traded technology and healthcare companies. Pitstick’s financial acumen and strategic insight is underscored by his role as a board member of a publicly traded financial services company, where he also serves as chairman of that board's audit committee.
As CFO, Pistick's expertise in leading mergers and acquisitions (M&A) will be pivotal. His experience in overseeing transactions exceeding $3 billion, coupled with his success in raising more than $1 billion in financing, enables him to guide Caldera Medical through its ambitious expansion plans, including strategic acquisitions that will enhance the company’s portfolio and market presence.
Caldera Medical is a medical device company solely focused on women’s health. It develops, manufactures, and markets surgical products for treating stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids. The firm aims to treat 1 million women in underserved populations globally by next year.